Leishmaniasis, Cutaneous - 26 Studies Found
Completed |
: Treatment of Cutaneous Leishmaniasis With Meglumine Antimoniate Versus Meglumine Antimoniate and Allopurinol : Leishmaniasis, Cutaneous : 2007-05-29 :
|
Available |
: Paromomycin for Individuals With Uncomplicated Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2012-06-18 : Drug: Paromomycin Paromomycin Topical Cream applied to all lesions once a day for 20 days |
Completed |
: Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2005-05-23 : Biological: Leish-111f + MPL-SE vaccine |
Terminated |
: Safety, Efficacy, and PK of Topical Paromomycin/Gentamicin Cream for Treatment of Cutaneous Leishmaniasis : Leishmaniasis, Cutaneous : 2010-06-07 : Drug: WR 279,396 Topical application of WR 279,396 cream (15% paromomycin + 0.5% gentamicin)once daily f |
Completed |
: Safety, Efficacy and Pharmacokinetics (PK) Study of WR 279,396 Versus Paromomycin for Treatment of Cutaneous Leishmaniasis (Peru-PK) : Leishmaniasis, Cutaneous : 2009-12-14 :
|
Completed |
: Pharmacokinetics, Safety, and Efficacy Trial of WR 279,396 (Paromomycin + Gentamicin Topical Cream) and Paromomycin Topical Cream for the Treatment of Cutaneous Leishmaniasis in Panama : Leishmaniasis, Cutaneous : 2010-03-08 :
|
Completed |
: Topical Treatment of Cutaneous Leishmaniasis With WR 279,396: A Phase 2 Study in the Old World : Cutaneous Leishmaniasis : 2008-06-20 :
|
Completed |
: Efficacy of Topical Liposomal Form of Drugs in Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2010-01-13 :
|
Completed |
: Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) : Cutaneous Leishmaniasis : 2008-01-21 :
|
Completed |
: Study of the Efficacy of Daylight Activated Photodynamic Therapy in the Treatment of Cutaneous Leishmaniasis : Cutaneous Leishmaniasis : 2009-02-08 :
|